159 related articles for article (PubMed ID: 17906204)
1. Prognostic significance of overexpression and phosphorylation of epidermal growth factor receptor (EGFR) and the presence of truncated EGFRvIII in locoregionally advanced breast cancer.
Nieto Y; Nawaz F; Jones RB; Shpall EJ; Nawaz S
J Clin Oncol; 2007 Oct; 25(28):4405-13. PubMed ID: 17906204
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
[TBL] [Abstract][Full Text] [Related]
3. Subtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlations and indications.
Chen C; Yuan JP; Wei W; Tu Y; Yao F; Yang XQ; Sun JZ; Sun SR; Li Y
Int J Nanomedicine; 2014; 9():1039-48. PubMed ID: 24591826
[TBL] [Abstract][Full Text] [Related]
4. The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer.
Chae YK; Gagliato Dde M; Pai SG; Carneiro B; Mohindra N; Giles FJ; Ramakrishnan-Geethakumari P; Sohn J; Liu S; Chen H; Ueno N; Hortobagyi G; Gonzalez-Angulo AM
PLoS One; 2016; 11(4):e0152585. PubMed ID: 27055285
[TBL] [Abstract][Full Text] [Related]
5. Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients.
DiGiovanna MP; Stern DF; Edgerton SM; Whalen SG; Moore D; Thor AD
J Clin Oncol; 2005 Feb; 23(6):1152-60. PubMed ID: 15718311
[TBL] [Abstract][Full Text] [Related]
6. Quantum dot-based quantitative immunofluorescence detection and spectrum analysis of epidermal growth factor receptor in breast cancer tissue arrays.
Yang XQ; Chen C; Peng CW; Hou JX; Liu SP; Qi CB; Gong YP; Zhu XB; Pang DW; Li Y
Int J Nanomedicine; 2011; 6():2265-73. PubMed ID: 22072864
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
Shinojima N; Tada K; Shiraishi S; Kamiryo T; Kochi M; Nakamura H; Makino K; Saya H; Hirano H; Kuratsu J; Oka K; Ishimaru Y; Ushio Y
Cancer Res; 2003 Oct; 63(20):6962-70. PubMed ID: 14583498
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer.
Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
Breast Cancer Res Treat; 2002 Jan; 71(1):67-75. PubMed ID: 11859875
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) status.
Torregrosa D; Bolufer P; Lluch A; López JA; Barragán E; Ruiz A; Guillem V; Munárriz B; García Conde J
Clin Chim Acta; 1997 Jun; 262(1-2):99-119. PubMed ID: 9204213
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor (EGFR) as a prognostic marker: an immunohistochemical study on 315 consecutive breast carcinoma patients.
Aziz SA; Pervez S; Khan S; Kayani N; Rahbar MH
J Pak Med Assoc; 2002 Mar; 52(3):104-10. PubMed ID: 12071064
[TBL] [Abstract][Full Text] [Related]
12. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.
Cheang MC; Voduc D; Bajdik C; Leung S; McKinney S; Chia SK; Perou CM; Nielsen TO
Clin Cancer Res; 2008 Mar; 14(5):1368-76. PubMed ID: 18316557
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of Ki-67 in breast cancer patients with positive axillary lymph nodes: a retrospective cohort study.
Li FY; Wu SG; Zhou J; Sun JY; Lin Q; Lin HX; Guan XX; He ZY
PLoS One; 2014; 9(2):e87264. PubMed ID: 24498305
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor expression in 780 breast cancer patients: a reappraisal of the prognostic value based on an eight-year median follow-up.
Ferrero JM; Ramaioli A; Largillier R; Formento JL; Francoual M; Ettore F; Namer M; Milano G
Ann Oncol; 2001 Jun; 12(6):841-6. PubMed ID: 11484962
[TBL] [Abstract][Full Text] [Related]
15. Type 1 growth factor receptor expression in node positive breast cancer: adverse prognostic significance of c-erbB-4.
Lodge AJ; Anderson JJ; Gullick WJ; Haugk B; Leonard RC; Angus B
J Clin Pathol; 2003 Apr; 56(4):300-4. PubMed ID: 12663644
[TBL] [Abstract][Full Text] [Related]
16. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F
J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.
Koutras A; Lazaridis G; Koliou GA; Kouvatseas G; Christodoulou C; Pectasides D; Kotoula V; Batistatou A; Bobos M; Tsolaki E; Papadopoulou K; Pentheroudakis G; Papakostas P; Pervana S; Petraki K; Chrisafi S; Razis E; Psyrri A; Bafaloukos D; Kalogeras KT; Kalofonos HP; Fountzilas G
PLoS One; 2018; 13(12):e0207707. PubMed ID: 30521571
[TBL] [Abstract][Full Text] [Related]
18. Coexpression, prognostic significance and predictive value of EGFR, EGFRvIII and phosphorylated EGFR in colorectal cancer.
Cunningham MP; Essapen S; Thomas H; Green M; Lovell DP; Topham C; Marks C; Modjtahedi H
Int J Oncol; 2005 Aug; 27(2):317-25. PubMed ID: 16010411
[TBL] [Abstract][Full Text] [Related]
19. Strong association of epidermal growth factor receptor status with breast cancer FDG uptake.
Lee J; Lee EJ; Moon SH; Kim S; Hyun SH; Cho YS; Choi JY; Kim BT; Lee KH
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1438-1447. PubMed ID: 28488029
[TBL] [Abstract][Full Text] [Related]
20. Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer.
Thor AD; Liu S; Edgerton S; Moore D; Kasowitz KM; Benz CC; Stern DF; DiGiovanna MP
J Clin Oncol; 2000 Sep; 18(18):3230-9. PubMed ID: 10986055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
